NCT00511992: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer |
|
|
| Completed | 2 | 20 | US | Avastin, Bevacizumab, Paclitaxel, Cisplatin | University of Oklahoma, Genentech, Inc. | Advanced Ovarian Carcinoma, Primary Peritoneal Carcinoma, Ovarian Carcinosarcoma | 08/15 | 08/15 | | |